Soft-tissue Sarcoma Supplement Now Online
Soft-tissue sarcomas have been, until recently, a neglected topic of investigation and publication. This is explained, in comparison with epithelial cancers, by a slower understanding of their pathogenesis and a lack of effective systemic therapies. The past few years, however, have seen changes in their classification, as well as improvements in their treatment, from surgery and radiotherapy to systemic therapy. Our Guest Editor, Dr. Thierry Alcindor (Associate Professor of Oncology & Medicine at McGill University) revisits soft-tissue sarcomas in this special journal issue.